Safety, Efficacy, and Patient Acceptability of Everolimus in the Treatment of Breast Cancer

Everolimus combined with exemestane is an important treatment option for patients suffering from estrogen receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer (ABC) who have been previously treated with a nonsteroidal aromatase inhibitor (NSAI). After presenta...

Descripción completa

Detalles Bibliográficos
Autores principales: Lousberg, Laurence, Jerusalem, Guy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214808/
https://www.ncbi.nlm.nih.gov/pubmed/28096680
http://dx.doi.org/10.4137/BCBCR.S12443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214808/
https://www.ncbi.nlm.nih.gov/pubmed/28096680
http://dx.doi.org/10.4137/BCBCR.S12443

Ejemplares similares